DVT DETECTION

• US 20120065523A1
• Filed: 12/20/2010
• Published: 03/15/2012
• Est. Priority Date: 10/20/2004
• Status: Abandoned Application

• Current Assignee: Huntleigh Technology, Inc.
• Original Assignee: Huntleigh Technology, Inc.
• Inventors: Gough, Nigel
• Application Number:
  US12/973,041
• Publication Number:
  US 20120065523A1
• Time in Patent Office: Days
• US Class Current: 600/479
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance
• CPC Class Codes: A61B 5/4035 Evaluating the autonomic nervous system
• CPC Class Codes: A61B 5/6829 Foot or ankle

Abstract

A device comprising a light transmission and detection system having transducers (10, 20, 7, 8), control means (5) and output means (7). The transducers are placed at various sites on the body of a patient and the light absorbed and/or reflected at these sites is measured and signals related to vasomotor activity are collected. The output can take the form of a detailed display of the vasomotor signals collected from the transducers (10, 20, 7, 8) to a simple indication of a condition present or absent. For example, the presence of a unilateral DVT can be detected by measuring the dissimilarity between two transducer signals from the soles of a patient'"'"'s feet. The invention can also be used to provide an indication or not of for example, DVT and diabetic peripheral neuropathy.

Claims

1. A vasomotor assessment method including the steps of:

a. obtaining measurements of the volume of blood in a first portion of the living body over time from a transducer situated on the first body portion;

b. within a processor;

(1) extracting from the blood volume measurements;

(a) frequencies representing the heart rate and the variation therein;

(b) frequencies representing vasomotion within the first body portion;

(2) comparing the frequencies representing vasomotion within the first body portion and the variation in the frequencies representing the heart rate;

c. providing an indication of the degree of neuropathy at the first body portion from an output device, the indication being dependent on the comparison.

2. The vasomotor assessment method of claim 1 wherein the method is performed while the living body is subjected to physiological stress.

3. The vasomotor assessment method of claim 1:

a. wherein the method is performed;

(1) while the living body is at rest, and

(2) while the living body is subjected to physiological stress;

b. comparing within the processor;

(1) the frequencies representing vasomotion within the first body portion while the living body is at rest, and

(2) the frequencies representing vasomotion within the first body portion while the living body is subjected to physiological stress;

the comparison providing an indication of the presence of neuropathy.

4. The vasomotor assessment method of claim 1 further including the steps of:

a. obtaining measurements of the volume of blood in a second portion of the living body over time from a transducer situated on the second body portion;

b. extracting frequencies representing vasomotion within the second body portion from the blood volume measurements at the second body portion;

c. comparing the frequencies representing vasomotion within the first body portion with frequencies representing vasomotion within the second body portion;

d. based on the comparison of frequencies, providing an indication of neuropathy from the output device.

5. The vasomotor assessment method of claim 4 wherein the comparison of the frequencies representing vasomotion within the first and second body portions includes determining phase differences between the frequencies.

6. The vasomotor assessment method of claim 1 further including the steps of:

a. obtaining measurements of the volume of blood in a second portion of the living body over time from a transducer situated on the second body portion;

b. determining within the processor phase differences between the vasomotion within the first body portion and the vasomotion within the second body portion;

c. based on the phase differences, providing an indication of neuropathy from the output device.

7. The vasomotor assessment method of claim 1 wherein the transducer includes a light detector detecting light coming from the living body.

8. A vasomotor assessment method including the steps of:

a. obtaining a measure of the variation in the heart rate of a living body;

b. obtaining a measure of the variation in the volume of blood carried in the blood vessels of a portion of the living body;

c. determining the similarity between the heart rate variation and the blood volume variation, the similarity providing a measure of neuropathy at the portion of the body.

9. The vasomotor assessment method of claim 8 wherein the method is performed by a diagnostic system including:

a. a transducer situated on the portion of the living body and taking measurements therefrom, and

b. a processor determining;

(1) the heart rate variation,

(2) the blood volume variation, and

(3) the similarity therebetween,

from the transducer measurements.

10. The vasomotor assessment method of claim 9 wherein the transducer includes:

a. a light emitter emitting light into the living body, and

b. a light detector detecting light coming from the body as a result of the emitted light.

11. The vasomotor assessment method of claim 9 wherein:

a. the diagnostic system further includes an output device, and

b. the method further includes the step of displaying the measure of neuropathy on the output device.

12. The vasomotor assessment method of claim 8 further including the steps of:

a. obtaining a measure of the blood volume variation at a first portion of the living body;

b. obtaining a measure of the blood volume variation at a second portion of the living body;

c. determining the similarity between the blood volume variations of the first and second body portions, the similarity providing an indication of whether thrombosis is present.

13. The vasomotor assessment method of claim 12 wherein the step of determining the similarity between the blood volume variations of the first and second body portions includes determining phase differences between peaks in the frequency spectra of the blood volume variations of the first and second body portions.

14. The vasomotor assessment method of claim 8 wherein the method is performed while the body is undergoing physiological stress.

15. The vasomotor assessment method of claim 8 further including the steps of:

a. obtaining a first measure of the blood volume variation at the portion of the living body while the body is at rest;

b. obtaining a second measure of the blood volume variation at the portion of the living body while the body is undergoing physiological stress;

c. determining the similarity between the first and second measures of the blood volume variation, the similarity providing a further measure of neuropathy at the portion of the body.

16. A vasomotor assessment method including the steps of:

a. situating transducers on first and second portions of a living body, the transducers capturing measures of vasomotion therefrom;

b. determining within a processor a measure of the similarity between the measures of vasomotion of the first and second body portions;

c. providing from an output device an indication of the presence of at least one of neuropathy and thrombosis.

17. The vasomotor assessment method of claim 16 wherein:

a. the first and second body portions are respectively located on different extremities of the living body, and

b. the output device provides at least an indication of the presence of neuropathy.

18. The vasomotor assessment method of claim 16 wherein:

a. the first and second body portions are located on a single extremity of the living body, and

b. the output device provides at least an indication of the presence of thrombosis.

19. The vasomotor assessment method of claim 16 wherein:

a. the transducers further capture a measure of the heart rate from at least one of the first and second body portions;

b. the processor further determines a measure of the similarity between;

(1) the measure of the vasomotion in at least one of the first and second body portions, and

(2) variation in the measure of the heart rate,

with the output device providing an output dependent on this measure of similarity.